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Abstract 
Background: Heterologous production of cold-adapted proteins currently represents one of the greatest bot-
tlenecks in the ongoing bioprospecting efforts to find new enzymes from low-temperature environments, such as, 
the polar oceans that represent essentially untapped resources in this respect. In mesophilic expression hosts such 
as Escherichia coli, cold-adapted enzymes often form inactive aggregates. Therefore it is necessary to develop new 
low-temperature expression systems, including identification of new host organisms and complementary genetic 
tools. Psychrophilic bacteria, including Pseudoalteromonas haloplanktis, Shewanella and Rhodococcus erythropolis have 
all been explored as candidates for such applications. However to date none of these have found widespread use as 
efficient expression systems, or are commercially available. In the present work we explored the use of the sub-Arctic 
bacterium Aliivibrio wodanis as a potential host for heterologous expression of cold-active enzymes.
Results: We tested 12 bacterial strains, as well as available vectors, promoters and reporter systems. We used RNA-
sequencing to determine the most highly expressed genes and their intrinsic promoters in A. wodanis. In addition 
we examined a novel 5′-fusion to stimulate protein production and solubility. Finally we tested production of a set 
of “difficult-to-produce” enzymes originating from various bacteria and one Archaea. Our results show that cold-
adapted enzymes can be produced in soluble and active form, even in cases when protein production failed in E. 
coli due to the formation of inclusion bodies. Moreover, we identified a 60-bp/20-aa fragment from the 5′-end of the 
AW0309160_00174 gene that stimulates expression of Green Fluorescent Protein and improves production of cold-
active enzymes when used as a 5′-fusion. A 25-aa peptide from the same protein enhanced secretion of a 25-aa-sfGFP 
fusion.
Conclusions: Our results indicate the use of A. wodanis and associated genetic tools for low-temperature protein 
production and indicate that A. wodanis represents an interesting platform for further development of a protein pro-
duction system that can promote further cold-enzyme discoveries.
Keywords: Aliivibrio wodanis, Heterologous protein production, Expression host, Psychrophilic enzymes, Cold 
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Background
The first recombinant proteins were produced in Escheri-
chia coli in 1976 [1]. Since then the production of recom-
binant proteins in E. coli has had great impact on our 
lives, for example, by eliminating the need to extract 
proteins from large volumes of native biological mate-
rial [2]. However, although the production of recombi-
nant proteins is a well-developed method, there are still 
challenges to overcome, and many variables to consider, 
such as, the expression host, plasmid vectors, promot-
ers, selection markers, affinity tags, and fusion partners. 
Strategies to increase production and avoid problems 
have been comprehensively reviewed in the past [3–6]. In 
particular, psychrophilic (cold-adapted) enzymes are dif-
ficult to express in conventional mesophilic hosts (such 
as E. coli) [7]. Psychrophilic enzymes originate from 
organisms living in cold environments, and with 80% of 
the earth’s biosphere being below 5 °C [8], the organisms 
living in these environments represent a largely untapped 
resource with respect to enzyme discovery.
Cold adapted enzymes are generally characterized by a 
higher catalytic activities at low temperatures, compared 
to their mesophilic homologs with rate enhancements up 
to tenfold [9]. Current understanding of this phenom-
enon are that the whole protein, or parts of it such as the 
active site, are destabilized due to the weakening of inter- 
and intramolecular bonds, thus increasing flexibility at 
low temperatures [10, 11]. Consequently, cold-adapted 
enzymes are thermolabile, melting at relatively low tem-
peratures meaning a relatively small increase in temper-
ature can lead to inactive protein. These properties can 
be highly beneficial in some commercial and biotechno-
logical applications [10, 12, 13]. One example is the use of 
cold-active enzymes as components of detergents, which 
reduces the need to heat water during washing. Another 
example is shrimp alkaline phosphatase which is com-
pletely inactivated after 5 min at 65 °C compared to calf 
intestinal alkaline phosphatase where a typical protocol 
for > 95% inactivation is 10  min at 70  °C. Less aggres-
sive heat inactivation can improve the quality of the final 
sample and simplify experimental protocols. Cold-active 
enzymes are therefore replacing some of the mesophilic 
enzymes already on the market. Progress in development 
of new cold-active enzymes is slow and severely ham-
pered by the lack of efficient protocols for the produc-
tion of proteins in active form. There is an urgent need 
to develop new tools, methods and expression hosts for 
low-temperature protein production.
Different strategies to improve expression of challeng-
ing enzymes in E. coli have been tried. These include 
decreasing the temperature during fermentation and 
manipulating the cell’s folding machinery by co-express-
ing chaperones/chaperonins/foldases, with a well-known 
example being the E. coli ArcticExpress strain [14, 15]. 
Another approach has been to refold proteins post 
expression, using (e.g., Urea, N-lauroylsarcosine, Dithi-
othreitol or 2-mercaptoethanol) and then refolding to 
active protein by removing the denaturant. However, for 
many proteins (especially enzymes), conventional refold-
ing methods are time consuming with recovered yields 
of active proteins being low due to use of aggressive 
chemicals during protein refolding [16–18]. A promising 
approach to improving expression of cold-active proteins 
is to use bacterial isolates that are naturally adapted to 
very low temperature as expression hosts. In microor-
ganisms that live in very cold locations, such as the bac-
terium Sphingopyxis alaskensis [19], a range of cellular 
processes are involved to ensure survival during exposure 
to low-temperature.
There have been several attempts in utilizing psychro-
philic bacteria as potential expression hosts. Yu et  al. 
[20] used the psychrophilic strain Pseudoalteromonas 
sp. SM20429 to successfully produce three cold-adapted 
Pseudoalteromonas enzymes. These proteins, protease 
(pseudoalterin), UDP-GlcNac 2-epimerase and UDP-
ManNAc dehydrogenase) were affinity purified in active 
form [20]. In addition, development of an expression sys-
tem based on Pseudoalteromonas haloplanktis TAC125 
including successful protein production at sub-zero 
temperatures [21–29]. Despite successful use of Pseu-
doalteromonas strains for production of cold-adapted 
proteins, one of the remaining issues is demonstration 
of protein expression from a wider phylogenetic range. 
Miyake et  al. addressed this using Shewanella sp. strain 
Ac10 and broad-host-range vector (pJRD215) to express 
β-lactamase, three putative peptidases (PepF, LAP, and 
PepQ), and a putative glucosidase (BglA), all originat-
ing from the psychrophilic bacterium, Desulfotalea 
psychrophila DSM12343 [30]. However, despite these 
successes, to date there are still no broadly available cold 
adapted protein production systems. The work described 
above is encouraging, but also shows that development 
of efficient systems for cold-temperature expression is 
far from trivial. Even though some of the criteria for suc-
cessful expression have been met there are still challenges 
to overcome. For example, even though there are reports 
of successful and stable growth of psychrophilic bacteria 
and protein production in fermenters under industrial-
like conditions to very high densities, more fine-tuning 
and optimization of protein production it still required 
[25, 28, 29]. Perhaps the most important prerequisites 
for a successful system are that the expression host must 
be able to grow fast to high densities at low temperatures 
and that genetic tools to introduce and genetically modify 
the bacterial genomic DNA are available. Other essential 
criteria are that the expression host can grow in cheap 
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growth media without requiring expensive supplements, 
which is especially important for industrial applications. 
Finally, the bacterium should not be pathogenic. One 
major drawback with developing new expression systems 
is that it requires extensive efforts to develop molecular 
tools, methods and protocols in order to achieve efficient 
production of target proteins.
Within our bacterial strain collection, mostly com-
prising of Sub-Arctic marine isolates, we noted that 
several Aliivibrio wodanis strains, of the Vibrionaceae 
family, grew fast at low temperatures. This observation 
and the fact that we had established genetic tools for 
closely related species e.g. Aliivibrio salmonicida [31–
33] encouraged us to pursue A. wodanis as a potential 
expression host for cold-adapted enzymes. In this work, 
we have evaluated properties of 12 A. wodanis strains, 
including growth, antibiotic resistance, the ability to take 
up DNA, to integrate DNA into its chromosomes, and 
to produce reporter systems [Green fluorescent protein 
(GFP), and Red Fluorescent Protein (RFP)] [34]. Promis-
ing strain candidates were further tested for production 
of cold-adapted enzymes originating from various genetic 
sources. Earlier attempts to produce some of these 
enzymes in E. coli had failed to generate soluble proteins. 
In order to increase expression levels in A. wodanis, we 
used RNA-sequencing to identify highly expressed genes 
and to design a 60-nt/20-aa fusion to increase expres-
sion levels. Overall, the results presented here show that 
A. wodanis has the capacity to produce cold-adapted and 
“difficult-to-produce” proteins in soluble and active form, 
and in this respect outperforms E. coli.
Results and discussion
Selection of strains and genetic tools
Table  1 shows the 12 A. wodanis strains that were 
selected from our in-house strain collection to iden-
tify promising expression host candidates. Strains were 
tested for growth rate, resistance against some com-
monly used antibiotics (in biotechnological applica-
tions), and conjugation efficiency (uptake and stability 
of plasmids). Preliminary tests showed that A. wodanis 
does not grow well at temperatures above 20 °C and has 
an optimal growth rate in the range 12–18 °C. All of the 
strains tested showed very similar growth profiles. Fig-
ure 1a shows growth in standard culture flasks for one 
representative strain (03/09/160). A. wodanis grows 
considerably faster at 12  °C than at 4  °C with dou-
bling times of 2.5 and 25 h, respectively. Moreover, A. 
wodanis uses 72 and 144  h to reach maximum optical 
densities, at 12  °C and 4  °C, respectively. At 12  °C the 
bacterium reaches  OD600nm = 7 in standard LB medium 
supplemented with 2.5% NaCl.
We then tested A. wodanis for resistance to anti-
biotics, four of which are commonly used in bio-
technological applications, namely carbenicillin, 
kanamycin, tetracycline and chloramphenicol. Resist-
ance of A. wodanis strains to ampicillin, nitrofuran-
toin, tetracyclines, cefoxitin and sulfamethoxazole has 
been reported [35]. The 12 strains used in this study 
were sensitive to chlorampenichol and tetracycline, 
had intermediate sensitivity to kanamycin and showed 
resistance to carbenicillin (see Table 1).
Table 1 Properties associated with A. wodanis strains used in this study
S. salar : Salmo salar (Atlantic salmon); O. mykiss : Oncorhynchus mykiss (Rainbow trout); G. morhua : Gadus morhua (Atlantic cod); CHL: chloramphenicol; TET: 
Tetracycline; CAR: Carbenicillin; KAN: Kanamycin; 0: Susceptible; 0.5: Intermediate Susceptible; 1:  Resistant. Abbreviations for antibiotics follow that of the American 
Society for Microbiology; NA: not analysed
a GenBank accession numbers. The accession number for strain 06/09/139 refers to the genome assembly













06/09/139 S. salar GCA_000953695.1 NA NA NA NA NA NA [54]
89/09/5532 (1) S. salar JQ361718 0 0 1 1 1 0.5 [55]
90/09/325 (5) S. salar JQ361719 0 0 1 1 1 0.5 [55]
02/09/569 (7) S. salar JQ361720 0 0 1 1 1 0.5 [55]
02/09/382 (8) S. salar JQ361721 0 0 1 1 1 0.5 [55]
01/09/401 (11) S. salar JQ361722 0 0 1 1 1 0.5 [55]
88/09/441 (12) (T) S. salar JQ361723 0 0 0.5 0.5 1 0.5 [55]
06/09/170 (27) S. salar JQ361727 0 0 1 1 0.5 0.5 [55]
06/09/178 (29) O.mykiss JQ361731 0 0 1 1 1 0.5 [55]
04/60/17347 (35) G.morhua JQ361730 0 0 1 1 1 0.5 [55]
03/09/160 (37) S. salar JQ361729 0 0 1 1 1 0.5 [55]
K7F1 150913 S. salar – 0 0 1 1 1 0.5 This study
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To test the ability of A. wodanis to take up plasmids, 
each strain was conjugated with the replicative vector 
pTM214 [36]. In E. coli, the mCherry fluorescent pro-
tein is constitutively expressed from pTM214, whereas 
expression of mCherry in A. wodanis requires addition 
of IPTG to the growth medium. The inability of E. coli 
to grow under propagation conditions permissive for A. 
wodanis provides a convenient method to select for A. 
wodanis cells after conjugation. As, only A. wodanis col-
onies carrying the pTM214 plasmid grow well to visible 
size. In addition, as the growth medium (agar plates) did 
not contain IPTG, A. wodanis colonies are identifiable by 
their lack of mCherry expression which is constitutively 
expressed from pTM214 in E. coli. Figure 1b shows that 
six of the 12 A. wodanis strains (i.e., strains 02/09/382, 
01/09/401, 88/09/441, 04/60/17347, 03/09/160 and K7F1 
150913) readily receive and accept the foreign plasmid 
(pTM214) through conjugation. The six recipient strains 
were then tested for their ability to receive and integrate 
the integrative plasmid pNQ705 [37]. A 250  bp DNA 
region homologous to the A. wodanis ainS gene was first 
inserted into pNQ705 to promote genomic integration. 
The test was performed using three experimental repli-
cates for each strain and regarded as positive if at least 
one integration into the bacterial host genome was found. 
Figure  1b shows that integration was found in strains 
02/09/382, 88/09/441, 04/60/17347, 03/09/160 and K7F1 
150913, i.e. five of six tested strains.
Next, we used the plasmid pVSV208 to determine the 
capacity of strains to produce a reporter protein, the 
red fluorescent protein (RFP), under antibiotic (chlo-
ramphenicol) pressure. Only strains that received the 
pTM214 plasmid were tested (see above). First, produc-
tion was monitored by examining the morphology (color) 
of colonies using a fluorescent microscope. Bright red 
colonies of strains 01/09/401 and 03/09/160 indicated 
strong RFP expression. Colonies of strains 02/09/382, 
04/60/17347 and K7F1 150913 were less bright. We 
observed considerable variation in strain 88/09/441 
where colonies ranged from bright red to white color 
indicating uneven expression levels in individual colo-
nies. Further, RFP production was monitored in liq-
uid cultures by measuring fluorescence (588  nm) in the 
supernatant of lysed cell cultures. Figure  1c shows that 
the relative fluorescence values are in good agreement 
with the colony morphologies described above. Again, 
strains 01/09/401, 88/09/441 and 03/09/160 produced 
highest fluorescence intensities.
In summary, based on the results described above 
strains 01/09/401 and 03/09/160 are the most promising 
candidates for production of proteins. Both strains grow 
well at low temperature to relatively high optical densi-
ties. Both can receive plasmids via conjugation, and can 
Fig. 1 Selection of A. wodanis strains. a Growth curve for A. wodanis 
strain 03/09/160 at 4 and 12 °C. Similar growth pattern was observed 
for all thirteen tested strains. Error bars represent standard deviation 
between three replicates. b Conjugation efficiency for 12 A. wodanis 
strains. Bars show uptake of pTM214 vector. Plus signs (+) indicate 
integration of pNQ705 vector into chromosome, strains that could 
not integrate pNQ705 vector into chromosome are missing (+) sign 
above bars. c Expression of RFP in six A. wodanis strains, that are able 
to uptake vectors via conjugation, containing pVSV208. Bars indicate 
measured relative fluorescence. RFU relative fluorescence units
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stably produce RFP. Strain 03/09/160 is additionally capa-
ble of integrating plasmids efficiently into its genome.
Production of green fluorescent protein reporter system 
at low temperature
Next, we tested the ability of A. wodanis strains to sup-
port production of a His-tagged green fluorescent pro-
tein (GFP). In a pre-experiment, cultures of A. wodanis 
03/09/160 containing pTM214_His-GFP were IPTG 
induced and showed that expression is strongly elevated 
from the Ptrc promoter after 48  h and 72  h (Additional 
file 1: Fig. S1). Figure 2 shows the result of a time series 
experiment with GFP production in six A. wodanis 
strains (02/09/382, 01/09/401, 88/09/441, 04/60/17347, 
03/09/160 and K7F1 150913). Strains 01/09/401 and 
03/09/160, followed by strain 88/09/441 produce highest 
RFU values, which is in overall agreement with the RFP 
expression data (above), although the exact order is not 
the same.
Protein production, purification and activity 
of cold‑adapted enzymes from the Aliivibrio genus
Having shown production of three reporter systems, 
mCherry, RFP and GFP, we next wanted to test “dif-
ficult-to-produce” cold-adapted enzymes. Test-cases 
were selected projects at the Norwegian Structure Biol-
ogy Center (NorStruct) that had been terminated due to 
unsuccessful or poor expression in E. coli. As test-cases 
we first selected two enzymes, Exonuclease I (AsExoI) 
and DNA Polymerase II (AsPolII) both from Aliivibrio 
salmonicida. The rationale was that expression had pre-
viously failed in E. coli due to the formation of inclu-
sion bodies and that the proteins originate from a close 
relative of A. wodanis, which was likely to improve the 
chances of successful expression. To determine which of 
the six tested strains was preferable for test production, 
each was transformed with pTM214 vector containing 
the AsExoI gene under IPTG inducible promoter (Ptrc). 
Figure  3 shows AsExoI protein bands visible for strains 
01/09/401, 88/09/441 and 03/09/160, which is in agree-
ment with RFP and GFP expression. Note that soluble 
(Sol) samples in Fig. 3 represent affinity purified sample 
from the His-tag on recombinant AsExoI. Based on this 
result and the additional characterizations described 
above, strain 03/09/160 was chosen as the “standard” 
expression strain for the remaining part of this study.
Figure 4 shows production, purification and activity of 
enzymes AsExoI and AsPolII. They were both expressed 
using strain 03/09/160, affinity purified on an IMAC col-
umn and visualized by SDS-PAGE. Bands representing 
both proteins are clearly visible and specific fluorescence 
molecular beacon-based assays showed dose-dependent 
exonuclease and DNA polymerase activities, respectively 
(see “Methods” for assay details), thus demonstrating that 
Fig. 2 Expression of GFP in A. wodanis. Expression of GFP (green fluorescent protein) was compared in six A. wodanis strains in a time series 
over 72 h from the plasmid pTM214_HIS-GFP. Expression was induced by adding 0.1 mM IPTG from the start of the experiment. Highest relative 
fluorescent unit (RFU) values were recorded from strains 01/09/401, 03/09/160 and 88/09/441. Strain 03/09/160 with no plasmid was used as 
control
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the proteins are expressed in active form at low tempera-
ture. To test for endogenous (background) exonuclease 
activity from the A. wodanis host, we also expressed GFP 
in a separate A. wodanis culture as a control. No residual 
exonuclease activity was detected in the control (Fig. 4c), 
which support that only activity of recombinant AsExoI 
exonuclease was measured in our assay.
Finally, we compared expression of the cold-active 
enzyme AsExoI in (i) A. wodanis 03/09/160 at 12 °C for 
3 days, and (ii) in E. coli at 20 °C for 5 h (see Additional 
file 1: Fig. S2). The result shows that AsExoI is expressed 
in high quantities in E. coli, but is lost from the soluble 
protein fraction. In contrast, AsExoI is expressed in lower 
quantities in A. wodanis, but is readily affinity purified 
from the soluble protein fraction and produce a distinct 
band on the gel.
A 60 bp/20‑aa fragment originating from a highly 
expressed gene (AW0309160_00174) elevates expression 
of a gfp fusion
In an attempt to increase the protein production in A. 
wodanis we adapted a strategy, in which the 5′-end of a 
highly expressed genes is used as a fusion partner, and 
added to the 5′-coding region of the target gene. Exam-
ples include the use of the secretion signals from PelB 
OmpC and CelB [38–40]. Another strategy was that 
the addition of a strong RNA stem-loop to the mRNA 
5′-end that could enhance expression [41]. To find the 
most highly expressed genes, we cultivated A. wodanis 
03/09/160 under our standard growth conditions, har-
vested cells at  OD600nm = 2 (exponential phase) and used 
RNA-sequencing.
Table 2 shows a list of the top ten most highly expressed 
genes in A. wodanis 03/09/160. Interestingly, the level of 
expression of gene AW0309160_00174 is 2.2 × higher 
than that of the second most highly expressed gene, 
Awod_I1528 and 3.1 × higher than that of number three 
on the list, Awod_I1596. A 300-bp region upstream of 
AW0309160_00174, the promoter region, was cloned 
into the pTM214 vector in front of gfp (the plasmid was 
named pTM214_P174_GFP) to verify that the promoter 
can support strong expression in A. wodanis (Fig. 5a).
Further analysis of AW0309160_00174 revealed that 
the first 60-bp of the 5′-coding region can potentially 
form a strong RNA secondary structure consisting 
of three base-paired regions, and two terminal loops 
(Fig. 5b). This 60-bp/20-aa sequence was next cloned into 
pTM214 in front of a gfp/C-terminal His-tag to moni-
tor any stimulating effect on protein production (from 
Plac). This construct was named pTM214_5′174GFP-His 
(Fig.  5c). Figure  5d shows a comparison of A. wodanis 
cells expressing GFP from pTM214_His-GFP and 
pTM214_5′174GFP-His. The addition of the 5′-fusion 
(60-bp/20-aa) results in a moderate increase in fluores-
cence in both uninduced and induced cells.
Production of cold‑adapted enzymes from non‑Aliivibrio 
microbial sources
The following four non-Aliivibrio enzymes were then 
selected for test-expression: (i) Exonuclease I (MvExoI) 
from Moritella viscosa (Gammaproteobacteria; Alte-
romonadales; Moritellaceae), (ii) ligase 1 (CsLig1) from 
Cenarchaeum symbiosum (Archaea; TACK group; Thau-
marchaeota; Cenarchaeales; Cenarchaeaceae), (iii) ligase 
6 (CpLig6) from Colwellia psychrerythraea (Gammapro-
teobacteria; Alteromonadales; Colwelliaceae) and (iv) 
alcohol dehydrogenase (AdhStrep) from Streptomyces 
(Actinobacteria; Streptomycetales; Streptomycetaceae).
These four genes were first cloned into the pTM214 
vector, but downstream protein production experi-
ments did not produce any detectable bands after SDS-
PAGE. Therefore, the same enzyme genes were then 
Fig. 3 Expression of Exonuclease I from A. salmonicida (AsExoI). Expression of AsExoI was compared in six A. wodanis strains. Arrowhead denotes 
bands with molecular weight (55.0 kDa) corresponding to AsExoI (verified by mass spectrometry). Produced protein was purified using His-tagged 
magnetic beads. WC whole cell, Sol IMAC-purified protein fraction, MW molecular weight marker
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cloned into pTM214 behind the 60-nt/20-aa fusion 
from gene AW0309160_00174 and conjugated into A. 
wodanis 03/09/160. Protein production was performed 
as described earlier. Figure  6 shows that bands corre-
sponding to all four proteins are clearly visible on gels 
when samples of fractions collected after affinity purifica-
tion of the His-tagged enzymes were run on SDS–poly-
acrylamide gels. Identity of bands was verified by mass 
spectrometry. Finally, activity of MvExoI was tested using 
the same assay as described for AsExoI (see above). The 
enzyme responds in a dose-dependent manner and is 
indeed expressed and purified in active form (Additional 
file  1: Fig. S3). This suggests that the 20-aa fusion does 
not interfere with enzyme activity.
To summarize, four enzymes originating from non-
Aliivibrio organisms, including organisms very distantly 
related to A. wodanis (e.g. CsLig1 from Archaea) were 
expressed and purified. The activity of Exonuclease I 
from M. viscosa was tested and found to be active. Inter-
estingly, the addition of a 60-nt/20-aa fusion, significantly 
increased the expression from not visible on gels to read-
ily visible. Adapting to a stronger promoter system like 
T7 may increase expression/protein production. Thus 
far, the greatest benefit of the A. wodanis system is the 
Fig. 4 Expression, purification and activity of AsExoI and AsPolII. Coomassie-stained SDS acrylamide gels showing expressed and affinity purified 
6 × His-AsExoI (a) and 6 × His-AsPolII (b). MW = molecular weight marker (Biorad protein standard), WC = whole cell extract, Sol = lysate soluble 
protein fraction. Immobilized metal affinity chromatography (IMAC) was done to purify 6 × His-tagged proteins, and proteins eluted in IMAC 
fractions are shown on the gels. Molecular weights of AsExoI ans AsPolII are theoretically 55.0 kDa and 91.4 kDa. Arrows heads indicate bands on 
geld that were identified as the desired enzyme targets. The activity of AsExoI (c) and AsPolII (d) was monitored by adding increasing concentrations 
of enzyme to molecular beacon substrate
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apparent increase in successful protein folding of cold-
adapted enzymes resulting from production of proteins 
at low temperature.
A 25‑aa peptide originating from AW0309160_00174 
enhances export of sfGFP
Figure  7a shows an SDS-PAGE of 5× concentrated 
total proteins from spent media after 48 h of growth (to 
 OD600 ~ 2) of A. wodanis 03/09/160 in a medium without 
high molecular weight proteins (5  g yeast extract, 25  g 
NaCl, 10  g casamino acids). A single band correspond-
ing to a protein originating from AW0309160_00174 is 
readily visible [identified by Tandem mass spectrometry 
(MS–MS)]. This result shows that the highly expressed 
gene AW0309160_00174 is responsible for producing 
the corresponding protein, which is exported out of the 
cell. This is corroborated by SignalP [42] that predicts the 
presence of a 25-aa signal peptide in the N-terminus of 
the corresponding protein.
To test if the AW0309160_00174 signal sequence can 
be used to translocate recombinantly expressed pro-
teins into the periplasm, or growth medium, a plas-
mid was constructed such that the 25-aa peptide was 
placed in front of the super folder GFP (sfGFP), result-
ing in a construct (named pTM214_174ss_sfGFP). When 
translocated to the periplasmic space, sfGFP is fluores-
cent [43]. A control construct (pTM214_sfGFP), which 
encodes sfGFP without the N-terminal 25-aa peptide 
was used in parallel experiments as a control, while A. 
wodanis 03/09/160 without vector was used as the con-
trol/blank. After 48  h of growth the fluorescence was 
determined in (i) growth media with cells, also referred to 
as “Whole Culture” (Fig. 7b), (ii) in the growth media (no 
cells) (Fig. 7c), and finally (iii) in the periplasm (Fig. 7d). 
Both sfGFP and the 25-aa-sfGFP fusion were detected 
in the growth media and periplasm. Interestingly, the 
25-aa peptide significantly enhances the translocation/
secretion of sfGFP (Fig.  7e). The relative fluorescence 
unit (RFU) measurements are approx. 2× when sfGFP 
is expressed as a 25-aa fusion. It has previously been 
reported that sfGFP itself can be used as a carrier protein 
in E. coli for secretion of recombinant fusion proteins, 
the authors of that study describe how the beta-barrel 
shape and negative charges on the molecule promotes 
translocation of the molecule [44]. This may explain the 
relatively high levels of secretion of sfGFP, even without 
the 25-aa signal peptide.
In summary, the first 25-aa originating from 
AW0309160_00174 enhance translocation of sfGFP into 
its surroundings, when used as an N-terminal fusion 
peptide. Secretion of recombinantly expressed proteins 
can have huge advantages, such as improved folding 
and post-translational modifications, easier downstream 
purification and processing, and compatibility with con-
tinuous culturing.
Conclusion
In this work we have used the sub-Arctic bacterium A. 
wodanis as an expression host for “difficult-to-produce” 
enzymes. Basic characterization of 12 strains suggested 
that several strains were useful and that strain 03/09/160 
was particularly suitable for expression. By using RNA-
sequencing we revealed that a 60-nt/20-aa sequence of 
the most highly expressed gene can be used as a 5′-fusion 
to enhance expression of the downstream fusion partner. 
Three reporter systems and six enzymes were produced 
at low temperature, the activity of two of the enzymes 
was confirmed by molecular beacon-based assays. An 
N-terminal fusion of a 25-aa peptide and sfGFP showed 
that the peptide can be used as a signal for secretion of 
recombinantly produced proteins.
The current issue with our system is the lower level of 
produced proteins when compared to E. coli. To increase 
production of recombinant proteins in A. wodanis to 
Table 2 Top-ten most highly expressed genes in A. wodanis 03/09/160
Gene nr. Product Base mean
AW0309160_00174 Unknown 212,918.07
AW0309160_02815 Phosphoenolpyruvate carboxykinase [ATP]—phosphoenolpyruvate carboxylase (pckA) 97,425.05
AW0309160_02905 ATP synthase subunit beta—ATP synthase F1sector subunit beta—F-ATPase subunit beta (atpD) 69,249.87
AW0309160_02075 30S ribosomal protein S1 (rpsA) 51,427.88
AW0309160_02664 50S ribosomal protein L16 (rplP) 45,942.99
AW0309160_02634 Hypotetical protein 42,958.71
AW0309160_02907 ATP synthase subunit alpha—ATP synthase F1sector subunit alpha—F-ATPase subunit alpha (atpA) 40,648.19
AW0309160_02646 DNA-directed RNA polymerase subunit alpha—RNApolymerase subunit alpha—transcriptase subunit 
alpha (rpoA)
37,931.23
AW0309160_00936 Alanine dehydrogenase (ald) 33,312.94
AW0309160_02673 Elongation factor Tu (tufB_1) 30,288.95
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levels similar to or higher than in E. coli, several differ-
ent approaches are available. These include modification 
of strain to remove potentially damaging nucleases and 
proteinases as well as changing expression promoters to 
more efficient one. To increase recombinant protein pro-
duction in non-modified strain, optimization of IPTG 
concentration would be first step, with increase of pro-
duction time, use of autoinduction media and switching 
to high cell density culturing in bioreactors presenting 
other options.
The global market for specialty enzymes is continu-
ously growing, driven by demands of the pharmaceutical 
industry, development of novel high-value enzymes, 
advancements in the biotechnology industry, the con-
tinued need for cost-efficient manufacturing process 
and calls for greener technologies. One major driver is 
an increasing demand for new enzymes that work effi-
ciently at low temperatures, due to the growing demands 
for cleaner and less environmentally damaging technolo-
gies. This work contributes to the development of use-
ful biotechnological tools to unlock further potential 
in developments in protein production systems, for the 
expression of cold-adapted enzymes, and possibly other 
unstable products such as, immunoglobulin fragments.
Fig. 5 Expression of gfp using a 5′-fusion sequence from AW0309160_00174. AW0309160_00174 was by RNA-sequencing identified in this study 
as the most highly expressed gene under our standard growth conditions. a Picture shows cell pellets of A. wodanis containing pTM214_P174_GFP 
(contains 300-bp of the AW0309160_00174 gene promoter), or no plasmid (control) in microcentrifuge tubes subjected to UV light. Bright green 
color shows strong expression of gfp. b Secondary structure model of the first 60-nt of AW0309160_00174 mRNA. The sequence was used as a 
5′-fusion to improve protein expression (gfp shown as example). c Schematic figure showing the expression cassettes of plasmids pTM214_His-GFP, 
pTM214_P174_GFP and pTM214_5′174_GFP. pTM214_P174_GFP contains a 300-bp region of the AW0309160_00174 promoter placed in front 
of gfp, and the latter contains a Ptrc promoter in front of a 60-nt/20-aa 5′-fusion from AW0309160_00174 followed by gfp. pTM214_5′174_GFP 
was used as backbone for cloning and expression of non-Aliivibrio enzyme test cases. c, d Fluorescence measurements of A. wodanis containing 
no plasmid (Control), pTM214_His-GFP or pTM214_5′174_GFP. Samples with (+) or without (−) IPTG are shown. Values are expressed as relative 
fluorescence units (RFU)
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Methods
Bacterial strains and growth conditions
Twelve A. wodanis strains used in this study are listed in 
Table  1. Bacteria were revived from storage at −  80  °C 
by transferring frozen cells onto Blood agar or Marine 
agar plates, and placing them at 12 °C for 24–48 h. After 
being revived, the cells were grown in LB (Lysogeny 
Broth) supplemented with 2.5% NaCl liquid cultures for 
1 week at 12 °C, or 2 weeks at 4 °C. Growth temperature 
was 12  °C with the exception of one experiment where 
expression of AsExoI was tested at 4 and 12 °C. In addi-
tion, during conjugative transfer of plasmids from E. coli 
CC118 λpir to A. wodanis where bacteria were grown 
in standard LB at 37  °C. Plasmid-carrying A. wodanis 
Fig. 6 Expression and purification of non-Aliivibrio “test-case” enzymes. Enzymes from a wider phylogenetic range were selected as test-cases. 
a MvExoI (Mw—55 kDa), Exonucleae I from Moritella viscosa. b AdhStrep (Mw—39 kDa), alkoholdehydrogenase from Streptomyces. c CpLig6 
(Mw—32 kDa), Ligase 6 from Colwellia psychrerythraea. d CsLig1 (Mw—66 kDa), Ligase 1 from Cenarchaeum symbiosum. Arrowheads indicate 
bands of expected size. MW = molecular weight marker. WC = whole cell extract, Sol = lysate soluble protein fraction. Immobilized metal affinity 
chromatography (IMAC) was done to purify 6 × His-tagged proteins, and proteins eluted in IMAC fractions are shown on the gels
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strains were always freshly made by conjugation before 
experiments and not revived from − 80 °C.
Antibiotic resistance test
Antibiotic susceptibility testing was done by streak-
ing A. wodanis cells onto LB plates supplemented 
with 2.5% NaCl and one of the following antibiotics: 
Chloramphenicol (2  µg/mL, Tetracycline (10  µg/mL), 
Carbenicillin (100 or 200 µg/mL) or Kanamycin (50 or 
100  µg/mL). A. wodanis was regarded as susceptible 
(score = 0) if no growth was detected, as interme-
diately susceptible (score = 0.5) if poor growth was 
detected, or as resistant (score = 1) if good growth was 
detected. The concentrations of antibiotics tested were 
similar to the recommended working concentrations 
for E. coli, except Chloramphenicol which was tested 
at 2  µg/mL (instead of 25  µg/mL). If the test scored 
as “resistant”, then the test was repeated using 2× the 
recommended concentration. All A. wodanis strains 
were streaked onto the same agar plate and grown at 
12 °C for 2 days.
Fig. 7 a SDS-PAGE of spent growth media of A. wodanis 03/09/160. The visible protein band was analyzed by LC–MS/MS and determined to 
originate from AW0309160_00174. b–d Measurement of fluorescence in whole culture, growth media and periplasm of A. wodanis 03/09/160 
expressing sfGFP (from plasmid pTM214_sfGFP) or a 25-aa-sfGFP fusion (from plasmid pTM214_174ss_sfGFP). Bacteria without vector was used as 
control/blank). e Relative secretion/translocation compared to total florescence. p value calculated with Student’s t- test
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Conjugation and plasmid uptake test
The capacity of A. wodanis to receive conjugative plas-
mids was tested using a tri-parental mating approach. 
E. coli CC118 λpir (pEVS104) [45] as helper strain and 
E. coli CC118 λpir (pTM214) [36] was used as a donor. 
For genome integration E. coli CC118 λpir (pNQ705) 
was used. Integration was performed according to a pre-
viously described method [33, 46]. E. coli strains were 
grown to  OD600 0.5–0.7 in LB medium with kanamycin 
(50  µg/mL) and chloramphenicol (20  µg/mL), respec-
tively, at 37 °C. “The recipient” A. wodanis was grown to 
 OD600 = 1–2 in 3 mL LB supplemented with 2.5% NaCl 
at 12  °C. One mL of bacteria were next pelleted and 
resuspended in LB medium to original volume. After a 
second centrifugation and resuspension 500 µL of donor, 
helper and recipient bacteria were mixed and pelleted 
by centrifugation. The supernatant was removed and the 
pellet was resuspended in a small volume of residual LB 
medium of approximately 20 µL. The bacterial mix was 
spotted on an LB agar plate with 2.5% NaCl and incu-
bated at 16  °C. Conjugates with replicating vectors, in 
this case pTM214, were incubated for 24  h, whereas 
those with integrating vectors, pNQ705, were incubated 
for 48 h. After incubation, bacteria were resuspended in 
LB with 2.5% NaCl and spread on selective agar contain-
ing 2 µg/mL chloramphenicol and incubated at 12 °C for 
3  days. E. coli do not grow under these conditions. The 
number of colonies on agar plates were finally counted to 
assess the efficiency of DNA uptake. Plasmids were rou-
tinely transferred into A. wodanis as described above for 
pTM214 or pNQ705.
Cloning
For test expression, genes of interest were PCR-amplified 
using primer pairs and a gateway plasmid (pET151/TEV/
D-TOPO or pENTR/TEV/TOPO) containing the target 
gene as the template. Amplified DNA was inserted into 
the vector pTM214 using Fast cloning technique, accord-
ing to protocol [47]. Primers and the resulting plasmids 
are shown in Additional file  2: Tables S1, S2. Addi-
tional file  2: Table  S2 indicates that pTM214 contains 
an mCherry gene. When pTM214 was used as a vector 
for other genes the mCherry gene was not present as it 
was replaced by the new gene. Non-Aliivibrio test cases 
were expressed with or without a 5′ fusion partner (DNA 
sequence: 5′-ATG AGT AAGC AAA TGA AGTT TGG 
ACT TCTT CCA GCA GCGA TCG CTG GTGC ATT ACT 
GAGC-3′) originating from A. wodanis 03/09/160 gene 
AW0309160_00174.
Superfolder GFP (sfGFP) [48, 49] was ordered as a syn-
thetic construct including an N-terminal TEV-site for 
later fusion-proteins and C-terminal His-tag (GeneArt 
Strings from Thermo Fisher), and cloned into vector 
pTM214 using FastCloning with primers as stated in 
Additional file  2: Table  S2. The resultant plasmid is 
named pTM214_sfGFP. To test if the AW0309160_00174 
signal sequence can be used to translocate recombinantly 
expressed proteins into the periplasm or growth medium 
a plasmid was constructed such that the 25-aa pep-
tide was placed in front of the super folder GFP (sfGFP) 
and cloned into pTM214 vector using FastCloning. The 
resulting construct was named pTM214_174ss_sfGFP.
Recombinant production and purification of His‑GFP
Six A. wodanis strains, conjugated with pTM214_His-
GFP were grown in 15 mL cultures in LB with 2.5% NaCl 
and 2 µg/mL chloramphenicol and 0.1 mM IPTG at 12 °C 
shaking at 200  rpm. GFP was expressed for 3  days at 
12 °C. 200 µL of culture was withdrawn from each sample 
and the cells pelleted in a micro centrifuge at 13 K rpm 
for 5 min. The bacterial pellet was lysed with 30 µL Bug-
Buster (MerckMillipore) according to the manufactur-
er’s protocol, incubated at room temperature for 30 min 
and finally pelleted. 25 µL of each supernatant was used 
to measure GFP fluorescence in a Spectramax Gemini 
(Molecular Devices) spectrophotometer at wavelength 
485–538 nm.
Recombinant production and purification of test cases
Protein production was done in strains K7F1 150913, 
02/09/382, 01/09/401, 88/09/441, 04/60/17347 and 
03/09/160 to verify that strains producing the highest 
amounts of RFP (Fig. 1c) also perform best when produc-
ing cold-adapted enzymes. Protein production was done 
in 15  mL LB supplemented with 2.5% NaCl, 2  µg/mL 
chloramphenicol and 0.1 mM IPTG for 3 days at 12  °C. 
After 3 days of expression, samples of whole cell extracts 
and soluble proteins were separated by SDS-PAGE. The 
same strains were used to produce AsExoI to verify pro-
tein production under the same conditions. The proteins 
produced were purified using His-tagged magnetic beads 
(His Mag Sepharose Ni, GE healthcare) according to pro-
tocol and separated using SDS page.
For large scale production and purification test-case 
proteins were produced in A. wodanis 03/09/160 from 
their respective plasmids (see Additional file 2: Table S2) 
by growing the bacterium in 1 L LB supplemented with 
2.5% NaCl, 2 µg/mL chloramphenicol and 0.1 mM IPTG 
for 3 days at 12 °C. Cells were then spun down (6000 rpm, 
30  min, 12  °C) and lysed in 30  mL lysis buffer (50  mM 
Tris pH 8.0, 750  mM NaCl, and 5% (v/v) glycerol) sup-
plemented with 1× Complete protease inhibitor cock-
tail (Roche) and 1 U/µL HL/SAN DNase (ArcticZymes). 
The cells were disrupted using a cell disruptor (Constant 
Systems, Ltd.) at 1.38 kbar for four cycles. The lysate 
was cleared by centrifugation at 20,000×g for 30 min at 
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4 °C. Affinity purification of test proteins was carried out 
on a 5  mL HisTrap HP column (GE Healthcare) equili-
brated with buffer A (50 mM Tris pH 8.0, 750 mM NaCl, 
5% (v/v) glycerol and 10 mM imidazole) using an ÄKTA 
purifier (GE Healthcare). The bound protein was eluted 
across a gradient of 0–100% buffer B (50 mM Tris pH 8.0, 
750 mM NaCl, 5% (v/v) glycerol and 500 mM imidazole). 
The purity of the protein was evaluated by SDS-PAGE 
and the identity of proteins was verified using a Tan-
dem mass spectrometry (MS–MS) service at the Tromsø 
University Proteomics Platform (TUPP), using Orbitrap 
Fusion Lumos or a Q-Exactive HF-X and analyzing data 
across NCBI bacteria and all entries and Swissprot, all 
entries databases.
Enzyme activity assays
The two enzyme activity assays used in this work are both 
based on so-called “molecular beacons”. Each “molecu-
lar beacon” consists of a hairpin shaped DNA oligonu-
cleotide with an internally quenched fluorophore (in this 
case FAM). TAMRA was used as the FAM quencher. 
Enzyme activities of affinity purified AsExoI and MvExoI 
were tested in 50 µL reactions containing the following: 
0.2  µM ssDNA “molecular beacon” substrate (5′-FAM-
CGC CAT CGG AGG TTC-TAMRA-3′), 50  mM Tris pH 
8.5, 30  mM  MgCl2, 1  mM DTT, 0.2  mg/mL BSA, 2% 
glycerol and 8.5  nM enzyme (Exonuclease I). The reac-
tion was carried out in a black 96-well fluorescence assay 
plate  (Corning®) and the increase in FAM fluorescence 
(excitation at 485 nm, emission at 518 nm) was measured 
as relative fluorescence units (RFU) at appropriate time 
intervals for over 40 min.
The activity assay for AwPolII was based on a molecu-
lar beacon probe (5′-GGC CCG TDabcylAGG AGG AAA 
GGA CAT CTT CTA GCA TFAMACG GGC CGT CAA 
GTT CAT G GCC AGT CAA GTC GTC AGA AAT TTC 
GCA CCA C-3′) (modified from [50]). The molecular bea-
con template consists of a 23mer loop that is connected 
by a GC-rich 8mer stem region. The 8-mer stem region 
consists of two 8 nucleotide sequences (indicated in ital-
ics) and a 43mer extension. The fluorophores Dabcyl 
and FAM are attached to the indicated “T” nucleotides. 
Due to the loop formation the fluorophores Dabcyl and 
FAM are in close proximity and thus quenched. Upon 
extension by DNA polymerase I of the primer (5′-GTG 
GTG CGA AAT TTC TGA C-3′) that is annealed to the 
molecular beacon template the stem is opened and the 
increase in distance of the two fluorophores is meas-
ured by the restoration of FAM fluorescence (excitation 
485 nm, emission 518 nm). The assay was monitored in 
50 µL reactions containing 0.2  µM substrate (molecu-
lar beacon) mixed with 0.2  mM dNTP in 1× reaction 
buffer (250 mM Tris–HCl, pH 8.5, 250 mM, KCl, 25 mM 
MgCl2) and 1× DB (1  mg/mL BSA, 5  mM DTT, 10% 
glycerol). The mixture was first incubated at 25  °C for 
5 min, and the reaction was started by adding the puri-
fied enzyme. Increase in fluorescence was measured 
(excitation 485 nm, emission 518 nm) for 15 min at 10 s 
intervals (total of 91 reads). All measurements were per-
formed in Corning black 96-well plate (Sigma Aldrich, 
CLS3991-25EA).
Isolation of proteins in growth media for SDS‑PAGE
A. wodanis  03/09/160 was grown in a media with 5  g 
yeast extract, 25  g NaCl and 10  g casamino acids. This 
media does not contain any high molecular weight 
protein when analysed on SDS-PAGE. The strain was 
grown for 48 h reaching  OD600 = 2. The culture was spun 
down and the supernatant was sterile filtered through a 
0.45  µM filter. The spent growth medium was then up-
concentrated 5 times using a spin filter with 3 K cut-off, 
to a protein concentration of 6.3  mg/mL. The concen-
trated growth medium was analyzed on SDS-PAGE and 
the protein was identified by the Tandem mass spectrom-
etry (MS–MS) service at the Tromsø University Prot-
eomics Platform (TUPP).
Isolation of periplasmic proteins
A culture of A. wodanis was centrifuged and the pel-
let was resuspended in a volume corresponding to 1/10 
of the original volume in periplasmic lysis buffer (0.2 M 
Tris–HCl pH 8.0, 200 g/L sucrose and 0.1 M EDTA). The 
suspension was incubated on ice for 20 min followed by 
centrifugation. A second step with  MgCl2 resulted in 
complete lysis of the cells. Here cold 5  mM  MgCl2 was 
added to the initial culture (1/20th the volume) and 
mixed. It was incubated for 20  min on ice after which 
whole mixture was centrifuge at 5000g for 40 min at 4 °C. 
Supernatant containing periplasmic proteins was col-
lected and used in further analysis.
Quantification of sfGFP in growth media and periplasm
A. wodanis 03/09/160 with or without vector containing 
sfGFP was grown in standard conditions in the presence 
of IPTG for 48 h. The fluorescence was determined using 
a Specktramax photometer (ex 485  nm, em 525  nm) in 
the following samples: 100 µL whole culture (media with 
cells), 100  µL supernatant and 50  µL of the periplasmic 
fraction (prepared as above).
RNA sequencing, genome sequencing and bioinformatics 
analyses
To find the most highly expressed genes A. wodanis 
03/09/160 was first grown under standard growth con-
ditions: LB supplemented with 2.5% NaCland harvested 
at  OD600nm = 2 (exponential phase). After cultivation, 
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total RNA was purified from cell pellets using the Mas-
terpure complete DNA and RNA purification kit (Epi-
centre) following the manufacturer’s protocol. The RNA 
quality was then determined using a Bioanalyzer and a 
Prokaryote Total RNA Pico Chip (Agilent Technologies). 
Five µg total RNA was then used in the Ribo-Zero rRNA 
Removal Kit (bacteria) (Epicentre) according to manufac-
turer instructions to remove ribosomal (r) RNA. Samples 
depleted in rRNA were ethanol precipitated and ana-
lyzed on a Bioanalyzer using mRNA Pico Chips (Agilent 
Technologies). RNA-sequencing libraries were generated 
from rRNA-depleted RNA samples using the ScriptSeq 
Complete library prep kit (Illumina) in combination with 
library size selection using a Pippin Prep cassette (Sage 
Science). The size selected cDNA library was sequenced 
with MiSeq Reagent Kit v3 with 2 × 75  bp read length 
over 150 cycles, generating 25 mill reads and 3.75 Gb.
Reads were quality checked using FastQC. Further 
analysis of the RNA-Seq data was performed using a Gal-
axy pipeline consisting of EDGE-pro v1.0.1 (Estimated 
Degree of Gene Expression in Prokaryotes) and DESeq 
to align the reads to the A. wodanis 03/09/160 genome, 
and estimate gene expression value as “baseMean” (mean 
expression level across all replicates). The RNA seq data-
sets are publically available at GEO (NCBI) or ArrayEx-
press (EBI) using the accession number PRJEB30658..
Genome sequencing
Total DNA was isolated from A. wodanis 03/09/160 
grown under standard conditions to stationary phase 
using Genomic-tip 100/g (Qiagen) according to the 
manufacturer’s protocol. The final DNA concentration 
and quality were measured using a Nanodrop 2000c 
(Thermo Scientific) instrument, and the integrity of high 
molecular weight DNA was examined on a 1% agarose 
gel. Genomic DNA was sequenced at the Norwegian 
Sequencing Centre (NSC) using the PacBio technology 
platform. Libraries were constructed using the PacBio 
20  kb library preparation protocol. Size selection of the 
final library was performed using BluePippin with a 7 kb 
cut-off. Libraries were sequenced on a Pacific Biosciences 
RS II instrument using P6-C4 chemistry with 360  min 
movie time. PacBio reads were assembled using HGAP 
v3 [51], and Minimus2 [52] was used to circularize con-
tigs. RS_Resequencing.1 software (SMRT Analysis ver-
sion v2.3.0) was used to map reads back to assembled and 
circularized sequence in order to correct sequence after 
circularization.
A final refinement of the genome sequence derived from 
the PacBio instrument was done by re-sequencing the A. 
wodanis 03/09/160 genome using a MiSeq Illumina instru-
ment and paired-end sequencing (i.e., 2 × 300-bp reads). 
The resulting reads were mapped onto the PacBio derived 
circularized sequence using the Bowtie 2 software to cor-
rect for potential single nucleotide errors that may occur 
due to the high error rate during PacBio sequencing [53]. 
The final genome sequence is publically available at ENA/
GenBank/DDBJ using the accession number PRJEB30658.
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